1. Academic Validation
  2. The SRm160/300 splicing coactivator is required for exon-enhancer function

The SRm160/300 splicing coactivator is required for exon-enhancer function

  • Proc Natl Acad Sci U S A. 1999 May 25;96(11):6125-30. doi: 10.1073/pnas.96.11.6125.
A G Eldridge 1 Y Li P A Sharp B J Blencowe
Affiliations

Affiliation

  • 1 Banting and Best Department of Medical Research, University of Toronto, Toronto, ON M5G 1L6, Canada.
Abstract

Exonic splicing enhancer (ESE) sequences are important for the recognition of splice sites in pre-mRNA. These sequences are bound by specific serine-arginine (SR) repeat proteins that promote the assembly of splicing complexes at adjacent splice sites. We have recently identified a splicing "coactivator," SRm160/300, which contains SRm160 (the SR nuclear matrix protein of 160 kDa) and a 300-kDa nuclear matrix antigen. In the present study, we show that SRm160/300 is required for a purine-rich ESE to promote the splicing of a pre-mRNA derived from the Drosophila doublesex gene. The association of SRm160/300 and U2 small nuclear ribonucleoprotein particle (snRNP) with this pre-mRNA requires both U1 snRNP and factors bound to the ESE. Independently of pre-mRNA, SRm160/300 specifically interacts with U2 snRNP and with a human homolog of the Drosophila alternative splicing regulator Transformer 2, which binds to purine-rich ESEs. The results suggest a model for ESE function in which the SRm160/300 splicing coactivator promotes critical interactions between ESE-bound "activators" and the snRNP machinery of the spliceosome.

Figures